Chromadex Corp
Change company Symbol lookup
Select an option...
CDXC Chromadex Corp
T AT&T Inc
BFCXX BlackRock Liquidity FedFund Fund Capital
VTR Ventas Inc
LTC LTC Properties Inc
CNK Cinemark Holdings Inc
TITN Titan Machinery Inc
AHL-C Aspen Insurance Holdings Ltd
EVBN Evans Bancorp Inc
CTXS Citrix Systems Inc
Go

Health Care : Life Sciences Tools & Services | Small Cap Growth
Company profile

ChromaDex Corp. is a global bioscience company, which is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. NAD+ is a coenzyme and a regulator of cellular metabolism. It operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.

Postmarket

Last Trade
Delayed
$1.66
-0.07 (-4.05%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$1.73
Day's Change
-0.10 (-5.46%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
1.89
Day's Low
1.72
Volume
(Light)
Volume:
226,539

10-day average volume:
459,544
226,539

Upcoming Events

CDXC's fiscal year ends in December
There are no upcoming events for CDXC

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
May 12, 2022Q1 2022 Earnings Release-$0.11-$0.12 to -$0.07-$0.12
March 9, 2022Q4 2021 Earnings Release-$0.08-$0.14 to -$0.07-$0.10
November 3, 2021Q3 2021 Earnings Release-$0.13-$0.11 to -$0.08-$0.07
August 3, 2021Q2 2021 Earnings Release-$0.08-$0.11 to -$0.05-$0.06

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.